1. Home
  2. ELDN vs BCBP Comparison

ELDN vs BCBP Comparison

Compare ELDN & BCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • BCBP
  • Stock Information
  • Founded
  • ELDN 2004
  • BCBP 2000
  • Country
  • ELDN United States
  • BCBP United States
  • Employees
  • ELDN N/A
  • BCBP N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • BCBP Savings Institutions
  • Sector
  • ELDN Health Care
  • BCBP Finance
  • Exchange
  • ELDN Nasdaq
  • BCBP Nasdaq
  • Market Cap
  • ELDN 239.6M
  • BCBP 203.2M
  • IPO Year
  • ELDN N/A
  • BCBP N/A
  • Fundamental
  • Price
  • ELDN $4.34
  • BCBP $12.07
  • Analyst Decision
  • ELDN Strong Buy
  • BCBP Hold
  • Analyst Count
  • ELDN 1
  • BCBP 2
  • Target Price
  • ELDN $16.00
  • BCBP $13.75
  • AVG Volume (30 Days)
  • ELDN 553.2K
  • BCBP 50.6K
  • Earning Date
  • ELDN 11-12-2024
  • BCBP 01-23-2025
  • Dividend Yield
  • ELDN N/A
  • BCBP 5.30%
  • EPS Growth
  • ELDN N/A
  • BCBP N/A
  • EPS
  • ELDN N/A
  • BCBP 1.17
  • Revenue
  • ELDN N/A
  • BCBP $89,636,000.00
  • Revenue This Year
  • ELDN N/A
  • BCBP N/A
  • Revenue Next Year
  • ELDN N/A
  • BCBP $6.99
  • P/E Ratio
  • ELDN N/A
  • BCBP $10.32
  • Revenue Growth
  • ELDN N/A
  • BCBP N/A
  • 52 Week Low
  • ELDN $1.43
  • BCBP $9.19
  • 52 Week High
  • ELDN $5.54
  • BCBP $14.04
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 42.46
  • BCBP 39.99
  • Support Level
  • ELDN $4.32
  • BCBP $12.27
  • Resistance Level
  • ELDN $4.76
  • BCBP $13.17
  • Average True Range (ATR)
  • ELDN 0.39
  • BCBP 0.47
  • MACD
  • ELDN -0.09
  • BCBP -0.13
  • Stochastic Oscillator
  • ELDN 2.65
  • BCBP 25.42

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection, and automated teller services.

Share on Social Networks: